Selexis empowers scientists and biopharmaceutical companies around the world to realize the full potential of their work.

Who we are

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.

SUREtechnology Platform

Our global partners are utilizing Selexis technologies to advance more than 100 drug products in clinical development and the manufacture of four commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks.

LOREM IPSUM

LATEST NEWS

XPRESSIONS BLOG

Selexis and IAVI: Advancing Possibilities in AIDS Vaccine Development

As a child growing up in Nigeria, I had first-hand experience of the suffering caused by debilitating diseases such as malaria. This fueled my interest in the life sciences and passion to positively impact human health by combating diseases of high unmet medical need, particularly in developing countries. Today, Nigeria has the second highest burden […]

RECENT AND UPCOMING EVENTS

October 10 – 12, 2018
Bio Japan, Yokahama, Japan

November 5 – 7, 2018
BIO Europe, Copenhagen, Denmark

November 5 – 8, 2018
JAACT 2018, Tsukuba, Japan

November 12-16, 2018
PEGS Summit Europe, Lisbon, Portugal

FULL CALENDAR



We are Social